Z_Biofield Therapy in Oncology: Modulation of Tumor Biology in Pancreatic and Liver Cancer (With Logo)

Biofield Therapy in Oncology: Modulation of Tumor Biology in Pancreatic and Liver Cancer

Objective

  • Confirmatory research and advancement of prior biofield therapy research in cancers with the highest rate of mortality, examining the relevant biological mechanisms of action through multidimensional monitoring, rigorous treatment/sham/control conditions, dosage modulation, blockage of biofield signal, and exploratory distance therapy

Hypothesis

  • Cancer cell mortality increases and proliferation decreases with biofield therapy relative to control and sham groups invitro and invivo in a way that is detectable not only through tumor remission/reduction but also by various biological markers

Projected Outcomes (In Process)

  • Biofield therapy mice have higher survival rates
  • Electromagnetic blocking of treatment does not prevent therapeutic effect
  • Animal behavior shifts during treatment
  • Change in neural correlates in therapists and mice during and after treatment
  • Alteration of cancer-related epigenetic markers
  • Alteration of cell signaling pathway proteins
  • Altered microbiome diversity/abundance
  • Immune modification, cytokines/immune cell profile
  • Stem cell marker alteration
  • Dosage effect is shown in audio treatment invitro
  • Distance treatment invitro is effective